Xencor Investigative Site
Kyiv, Ukraine
65 recruiting
Showing 1–6 of 6 trials
Recruiting
Phase 1Phase 2
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Ulcerative Colitis (UC)
Xencor, Inc.270 enrolled90 locationsNCT06619990
Recruiting
Phase 1
Phase 1, Safety and Tolerability Study of XmAb541 and XmAb808 in Advanced Solid Tumors
Ovarian Cancer
Xencor, Inc.90 enrolledNCT07593092
Recruiting
Phase 1
A Phase 1 Open-label Study to Evaluate Safety in Healthy Participants and Participants With Autoimmune Diseases
HealthyIdiopathic Inflammatory MyopathiesSystemic Sclerosis+1 more
Xencor, Inc.60 enrolled1 locationNCT07284797
Recruiting
Phase 1
Study of XmAb412 in Healthy Participants
Not Applicable - Healthy Adult Participants
Xencor, Inc.128 enrolled2 locationsNCT07713485
Recruiting
Phase 1
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
Clear Cell Renal Cell Carcinoma
Xencor, Inc.307 enrolled26 locationsNCT05433142
Recruiting
Phase 1
A Phase 1b Open-label Study to Evaluate Safety of Plamotamab in Participants With Rheumatoid Arthritis
Rheumatoid Arthritis
Xencor, Inc.68 enrolled3 locationsNCT07230353